Trial Information
Long-term Anastrozole Versus Tamoxifen Treatment Effects (LATTE)
Inclusion Criteria:
- patients randomised to one of the monotherapy arms in the ATAC Trial
- alive at 10 years follow-up
Exclusion Criteria:
- patients who have withdrawn consent to participate in the ATAC Trial or this study
- where the LATTE Executive Committee determines that there is no possibility of
obtaining follow-up
Type of Study:
Observational
Study Design:
N/A
Outcome Measure:
Time to recurrence
Outcome Description:
Time to recurrence of breast cancer in the post 10 year period (defined as the earliest of local or distant recurrence, new primary breast cancer, or death)
Outcome Time Frame:
LATTE particpants who are 10 years post treatment will be followed for 5 years for the purpose of this study.
Safety Issue:
No
Principal Investigator
Robert Smith, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
American Cancer Society, Inc.
Authority:
United States: Institutional Review Board
Study ID:
IRB00050408
NCT ID:
NCT01745289
Start Date:
February 2013
Completion Date:
January 2018
Related Keywords:
- Breast Cancer
- Breast Cancer
- Survival
- Recurrence
- Breast Neoplasms